The CRISPR patent landscape in 2026 is a complex maze for biotech startups. This article dissects the current state, future implications, and strategic pathways for navigating intellectual property in gene editing.

Prepare for a thriving career in biotechnology! Our insider's guide highlights the top 3 in-demand biotech skills crucial for US job seekers in 2026, offering insights into bioinformatics, gene editing, and AI integration for future success.

This article provides a comprehensive, data-driven comparison of five highly anticipated US biotech IPOs projected for 2026. We delve into their therapeutic areas, clinical pipelines, market opportunities, and potential risks, offering valuable insights for investors eyeing the next big wave in biopharmaceutical innovation.

This article highlights the top 3 virtual US biotech events scheduled for late 2026, offering practical solutions for professionals to maximize engagement, network effectively, and stay ahead in the dynamic biotechnology sector.

Discover expert strategies to negotiate a 15% higher biotech salary by 2026. This guide covers market research, skill enhancement, and negotiation techniques essential for US biotech professionals seeking significant financial advancement.

The year 2026 marks a significant turning point in the pharmaceutical industry with the patent expiration of seven blockbuster drugs. This presents unique investment opportunities in generic and biosimilar manufacturers, as well as for innovative companies poised to fill market gaps. Understand the financial implications and strategic moves for investors.